BMC Cancer — Journal Profile & Submission Links
BioMed Central Ltd · ISSN-L 1471-2407
BMC Cancer publishes articles in oncology.
Listed metrics: Q2, open access, APC $3550, OpenAlex 2-year citedness 3.4.
Authors checking fit can use the scope note and the official links on this profile.
→ Check whether your manuscript fits this journal, free
This page provides a source-backed journal profile and links to official submission resources. Journal instructions can change. Always verify article types, formatting, fees, ethics requirements, and submission rules on the official journal website before submitting.
Official links
- Journal homepage
- bmccancer.biomedcentral.com
- Author guidelines
- bmccancer.biomedcentral.com/submission-guidelines
The journal's own scope statement
The text below is the catalog scope statement for this journal.
BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials. The journal welcomes manuscripts in the following broad areas of research: Cell and molecular biology including all aspects of tumor biology from a molecular and cellular point of view. Topics of interest include animal models, hypoxia, angiogenesis, metastasis, cellular signaling, cancer stem cells, DNA damage and repair, cell cycle and apoptosis. Biomarker studies we will publish studies of diagnostic and prognostic markers which may ultimately be applicable in a clinical setting. Please see further information below. Cancer epidemiology related cancer research including all aspects of cancer epidemiology including risk factors for disease initiation and development, social determinants, environmental, behavioural, and occupational correlates. Experimental therapeutics and drug development including all aspects of preclinical investigations on therapeutic agents. It welcomes submissions concerning anti-cancer drug discovery and development, and targeted therapies. Genetics, genomics and epigenetics including all aspects of genome-scale analysis, functional genomics, genetic association studies, pharmacogenomics and epigenetics in relation to cancer biology, diagnosis and therapy. Tumour immunology including on all aspects of infectious agents associated with cancer and tumor immunology. Topics of interest include, but are not limited to, tumor immunity, immunotherapy, cancer vaccines, viral carcinogenesis and virus-host interactions. Therapy studies with focus on clinical research that impacts on the treatment of cancer using systemic chemotherapy, immunotherappy, targeted therapy, and radiation. We further welcome submissions on research looking at therapy resistance mechanisms. Surgical oncology with focus on clinical research that impacts on the diagnosis and treatment of cancer using surgery, diagnostic imaging, interventional therapeutics, and surgical pathology.
Catalog source: merged. This is not a copy of the publisher's author instructions.
For review time and acceptance rate, see the journal's official author guidelines. bmccancer.biomedcentral.com/submission-guidelines
General pre-submission checks for medical manuscripts
Generic checklist only — not journal-specific requirements.
- Confirm scope fit and intended article type on the official journal site.
- Abstract structure matches the journal's current requirements.
- Ethics approval and trial registration statements are complete.
- Informed consent and patient privacy statements are in place.
- Reporting guideline compliance (e.g. CONSORT, STROBE, PRISMA) as applicable.
- Reference style and citation limits per official guidelines.
- Figures and tables meet resolution, labeling, and count limits.
- Cover letter addresses novelty, fit, and required declarations.
- Conflicts of interest statement included.
- Funding statement included.
- Data availability statement included when required.